Abstract

BackgroundHepatic dysfunction and coagulopathy are common in acute dengue illness. We analyzed the trajectories of the above parameters in the survivors and fatal patients in the outbreak in Tainan, 2015.MethodsA retrospective study was conducted using data from a tertiary hospital between January and December 2015. Multilevel modeling (MLM) was used to identify the changes in aminotransferase (AST), alanine aminotransferase (ALT), activated partial thromboplastin time (aPTT), and platelet counts from Day 0 to Day 7 of the onset of dengue infection. The machine-learning algorithm was used by purity measure assumption to calculate the accuracy of serum transaminases and coagulation variables to discriminate between the fatal and survival groups.ResultsThere were 4,069 dengue patients, of which 0.9% died in one week after illness onset (i.e., early mortality). Case fatality rate was the highest for those aged ≥70 years. Both AST and ALT values of the fatal group were significantly higher than those of the survivor group from Day 3 (AST median, 624 U/L vs. 60 U/L, p < 0.001; ALT median, 116 U/L vs. 29 U/L, p = 0.01) of illness onset and peaked on Day 6 (AST median, 9805 U/L vs. 90 U/L, p < 0.001; ALT median, 1504 U/L vs. 49 U/L, p < 0.001). AST ≥ 203 U/L, ALT ≥ 55 U/L, AST2/ALT criteria ≥337.35, or AST/platelet count ratio index (APRI) ≥ 19.18 on Day 3 of dengue infection had a high true positive rate, 90%, 78%, 100%, or 100%, respectively, of early mortality. The platelet counts of the fatal group declined significantly than those of the survivor group since Day 3 of illness onset (median, 19 x103/μl vs. 91 x103/μl, p < 0.01), and aPTT values of the fatal group significantly prolonged longer since Day 5 (median, 68.7 seconds vs. 40.1 seconds, p < 0.001).ConclusionsAST, ALT, and platelet counts should be monitored closely from Day 0 to Day 3 of dengue infection, and aPTT be followed up on Day 5 of infection to identify the individuals at risk for early mortality.

Highlights

  • Dengue incidence has risen 30-fold in the past fifty years globally, with the South-East Asia and Western Pacific Regions being the most affected regions with an approximately 1% fatality rate [1]

  • AST, alanine transaminase (ALT), and platelet counts should be monitored closely from Day 0 to Day 3 of dengue infection, and activated partial thromboplastin time (aPTT) be followed up on Day 5 of infection to identify the individuals at risk for early mortality

  • There were no differences in AST, ALT, aPTT, and platelet counts between the survivor and fatal groups on the day dengue fever (DF) symptoms first appeared, the differences increased from the early stages of infection and became more prominent during the early stages of the illness

Read more

Summary

Background

Hepatic dysfunction and coagulopathy are common in acute dengue illness. We analyzed the trajectories of the above parameters in the survivors and fatal patients in the outbreak in Tainan, 2015. Data Availability Statement: Data cannot be shared publicly because of the confidentiality of patients’ records. For those interested in the original data used for these analyses, please contact the National Cheng Kung University Hospital Institutional Review Board, the ethics committee in NCKUH (contact via TEL: 886-62353535 ext.3635, FAX: 886-6-2388190, E-mail: em73635@mail.hosp.ncku.edu.tw)

Methods
Results
Author summary
Introduction
Study design and study population
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.